Skip to main content
Clinical Trials/JPRN-UMIN000032182
JPRN-UMIN000032182
Completed
未知

Prospective Observational Study of Efficacy and Safety in Chemotherapy After Refractory or Intolerant to Nivolumab Therapy for Unresectable Advanced or Recurrent Gastric Cancer - REVIVE study (CSPOR GC-01)

Public Health Research Foundation0 sites200 target enrollmentApril 10, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Public Health Research Foundation
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 10, 2018
End Date
March 31, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patients for whom the attending physician considered enrollment in the study inappropriate

Outcomes

Primary Outcomes

Not specified

Similar Trials